Lou Gehrig's disease

Kevin Eggan PhD

Biotech

Amgen backs Harvard professors’ ALS startup QurAlis

Amgen joined with MP Healthcare Venture Management and Alexandria Venture Investments to put the latest tranche of funding into QurAlis.

Nick Paul Taylor Apr 5, 2018 9:02am

Spotlight

Cytokinetics cans lead drug after phase 3 ALS wipeout

Nov 21, 2017 9:00am

Brain imaging

ALS upstart Amylyx gains $3M grant to start combo trial

Jul 20, 2016 8:00am